PH13611A - Trisubstituted 1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepine - Google Patents

Trisubstituted 1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepine

Info

Publication number
PH13611A
PH13611A PH20427A PH20427A PH13611A PH 13611 A PH13611 A PH 13611A PH 20427 A PH20427 A PH 20427A PH 20427 A PH20427 A PH 20427A PH 13611 A PH13611 A PH 13611A
Authority
PH
Philippines
Prior art keywords
benzazepine
trisubstituted
tetrahydro
phenyl
Prior art date
Application number
PH20427A
Other languages
English (en)
Inventor
J Weinstock
Original Assignee
Smithkline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Corp filed Critical Smithkline Corp
Publication of PH13611A publication Critical patent/PH13611A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/575—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D497/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D497/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
PH20427A 1976-11-17 1977-11-11 Trisubstituted 1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepine PH13611A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/742,965 US4160765A (en) 1976-11-17 1976-11-17 Method for 6-bromination of 1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine compounds

Publications (1)

Publication Number Publication Date
PH13611A true PH13611A (en) 1980-08-05

Family

ID=24986959

Family Applications (2)

Application Number Title Priority Date Filing Date
PH20427A PH13611A (en) 1976-11-17 1977-11-11 Trisubstituted 1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepine
PH21605A PH14740A (en) 1976-11-17 1978-09-14 Trisubstituted 1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepine compounds

Family Applications After (1)

Application Number Title Priority Date Filing Date
PH21605A PH14740A (en) 1976-11-17 1978-09-14 Trisubstituted 1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepine compounds

Country Status (37)

Country Link
US (1) US4160765A (de)
JP (3) JPS5363335A (de)
AR (1) AR224495A1 (de)
AT (1) AT362379B (de)
AU (1) AU509754B2 (de)
BE (1) BE860774A (de)
BG (1) BG30019A3 (de)
CA (1) CA1092107A (de)
CH (1) CH635079A5 (de)
CS (1) CS219333B2 (de)
CY (1) CY1246A (de)
DD (1) DD133563A5 (de)
DE (1) DE2751258A1 (de)
DK (1) DK156057C (de)
ES (1) ES464044A1 (de)
FI (1) FI67374C (de)
FR (1) FR2371430A1 (de)
GB (1) GB1595502A (de)
HU (1) HU176709B (de)
IE (1) IE46087B1 (de)
IL (1) IL53377A (de)
IN (1) IN150172B (de)
IT (1) IT1126216B (de)
LU (1) LU78513A1 (de)
MX (1) MX4682E (de)
MY (1) MY8500382A (de)
NL (2) NL185563C (de)
NO (1) NO147029C (de)
PH (2) PH13611A (de)
PL (1) PL109672B1 (de)
PT (1) PT67260B (de)
RO (1) RO72905A (de)
SE (1) SE436646B (de)
SG (1) SG31784G (de)
SU (1) SU976847A3 (de)
YU (1) YU40490B (de)
ZA (1) ZA775910B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4197297A (en) * 1976-11-17 1980-04-08 Smithkline Corporation 6-Halo-7,8-dihydroxy-1-(hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepines
JPS5481290A (en) * 1977-11-17 1979-06-28 Smithkline Corp Benzazepin compound
US4171359A (en) * 1978-04-12 1979-10-16 Smithkline Corporation Benz-tetrasubstituted 1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
ZA792042B (en) * 1978-05-08 1980-05-28 Scherico Ltd Substituted 8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepines,process for the preparation thereof and pharmaceutical compositions containing them
US4251525A (en) * 1979-05-25 1981-02-17 Smithkline Corporation 3-Allyl-7,8-dihydroxy-6-halo-1-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine derivatives
ATE5634T1 (de) * 1979-07-10 1984-01-15 Smithkline Beckman Corporation Synergistische blutdrucksenkende zusammensetzungen.
US4285938A (en) * 1979-10-11 1981-08-25 Smithkline Corporation 7,8-Dihydroxy-1-(sulfamylphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine derivatives
US4284556A (en) * 1980-01-31 1981-08-18 Smithkline Corporation 7,8-Amino, hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
US4328153A (en) * 1980-07-17 1982-05-04 Smith Kline Corporation Dopaminergic benzazepines
ATE15762T1 (de) * 1981-12-08 1985-10-15 Smithkline Beckman Corp Pharmazeutische zusammensetzungen mit gehalt an 7,8-dihydroxy-1-(hydroxy-phenyl)-2,3,4,5tetrahydro-1h-3-benzazepin-derivaten und an einem beta-adrenergischen blocker.
US4782163A (en) * 1984-10-05 1988-11-01 Smithkline Beckman Corporation 2-(2-halo-3,4-dimethoxybenzyl)-5-(4-methoxyphenyl)-oxazolidines
US4705862A (en) * 1984-10-05 1987-11-10 Smithkline Beckman Corporation Chemical processes for 2-(2-halo-3,4-dimethoxybenzyl)-5-(4-methoxyphenyl)oxazolidines
US5068326A (en) * 1989-04-03 1991-11-26 Kung Hank F Dopamine receptor ligands and imaging agents
KR20010113006A (ko) * 2000-06-15 2001-12-24 주정호 항암제로서 유용한 ｎ-치환된 벤즈아제피닐우레아 유도체및 그의 제조방법
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
US7090830B2 (en) 2001-05-24 2006-08-15 Alexza Pharmaceuticals, Inc. Drug condensation aerosols and kits
US7585493B2 (en) 2001-05-24 2009-09-08 Alexza Pharmaceuticals, Inc. Thin-film drug delivery article and method of use
US7766013B2 (en) 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US20040105818A1 (en) 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
US7913688B2 (en) 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
EP1625334B9 (de) 2003-05-21 2012-07-25 Alexza Pharmaceuticals, Inc. Schlag gezündete unabhängige heizeinheit
GB0412314D0 (en) * 2004-06-02 2004-07-07 Glaxo Group Ltd Compounds
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
CA2576961A1 (en) 2004-08-12 2006-03-02 Alexza Pharmaceuticals, Inc. Aerosol drug delivery device incorporating percussively activated heat packages
CA2593667A1 (en) * 2005-01-24 2006-07-27 Sicor Inc. Process for the preparation of fenoldopam mesylate
EP2121088B1 (de) 2007-03-09 2016-07-13 Alexza Pharmaceuticals, Inc. Erhitzungseinheit zur verwendung in einer arzneimittelabgabevorrichtung
CN103172565A (zh) * 2011-12-22 2013-06-26 四川科伦药物研究有限公司 一种手性菲诺多泮的拆分方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3393192A (en) * 1965-04-26 1968-07-16 Schering Corp Novel benzazepines
CH498122A (de) * 1968-02-09 1970-10-31 Geigy Ag J R Verfahren zur Herstellung eines neuen Tetrahydroazepinderivates
CH555831A (de) * 1967-02-17 1974-11-15 Scherico Ltd Verfahren zur herstellung von neuen benzazepinen.
GB1118688A (en) * 1967-02-17 1968-07-03 Scherico Ltd Novel benzazepines and process for making same
DE1695844C3 (de) * 1967-02-21 1980-01-17 Scherico Ltd., Luzern (Schweiz) l-Phenyl-23,43-tetrahydro-lH^benzazepin-Derivate und sie enthaltende pharmazeutische Zusammensetzungen
US3609138A (en) * 1967-12-22 1971-09-28 Ciba Geigy Corp 1-aryl-3-benzazepines
US4011319A (en) * 1975-07-02 1977-03-08 Smithkline Corporation Pharmaceutical compositions and methods involving benzazepine derivatives

Also Published As

Publication number Publication date
FR2371430A1 (fr) 1978-06-16
FI67374B (fi) 1984-11-30
FR2371430B1 (de) 1980-06-27
PL109672B1 (en) 1980-06-30
US4160765A (en) 1979-07-10
SU976847A3 (ru) 1982-11-23
JPS6225658B2 (de) 1987-06-04
CA1092107A (en) 1980-12-23
MY8500382A (en) 1985-12-31
AU509754B2 (en) 1980-05-22
PT67260A (en) 1977-12-01
AT362379B (de) 1981-05-11
CS219333B2 (en) 1983-03-25
NL7712567A (nl) 1978-05-19
LU78513A1 (de) 1978-03-20
JPS5363335A (en) 1978-06-06
HU176709B (en) 1981-04-28
JPS6366808B2 (de) 1988-12-22
NO147029C (no) 1983-01-19
SE7712944L (sv) 1978-05-18
NL930026I2 (nl) 1993-11-01
NL185563B (nl) 1989-12-18
BG30019A3 (en) 1981-03-16
DK500477A (da) 1978-05-18
SE436646B (sv) 1985-01-14
PH14740A (en) 1981-11-20
DK156057B (da) 1989-06-19
JPS62155218A (ja) 1987-07-10
JPS6125697B2 (de) 1986-06-17
AR224495A1 (es) 1981-12-15
DE2751258A1 (de) 1978-06-01
ATA816377A (de) 1980-10-15
FI67374C (fi) 1985-03-11
JPS58113153A (ja) 1983-07-05
RO72905A (ro) 1981-11-04
FI773448A (fi) 1978-05-18
YU270777A (en) 1983-02-28
CY1246A (en) 1984-08-31
IN150172B (de) 1982-04-07
ES464044A1 (es) 1978-08-01
SG31784G (en) 1985-03-08
DE2751258C2 (de) 1990-01-04
PL202177A1 (pl) 1978-09-25
BE860774A (fr) 1978-05-16
DK156057C (da) 1989-11-13
NL930026I1 (nl) 1993-06-01
IL53377A (en) 1982-09-30
IT1126216B (it) 1986-05-14
CH635079A5 (de) 1983-03-15
NO147029B (no) 1982-10-11
PT67260B (en) 1979-04-18
NL185563C (nl) 1990-05-16
MX4682E (es) 1982-07-28
IL53377A0 (en) 1978-01-31
IE46087B1 (en) 1983-02-23
YU40490B (en) 1986-02-28
DD133563A5 (de) 1979-01-10
IE46087L (en) 1978-05-17
AU3062677A (en) 1979-05-24
GB1595502A (en) 1981-08-12
NO773901L (no) 1978-05-19
ZA775910B (en) 1978-05-30

Similar Documents

Publication Publication Date Title
PH13611A (en) Trisubstituted 1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepine
PH13932A (en) 1,2,3,4-tetrahydro-napthalenes
PT66902B (en) Novel 1(2-aryl-2-r-ethyl)-1h-1,2,4-triazoles
GB1524917A (en) Gona-1,9(10)-dienes
AU517020B2 (en) 10, 19-dihydro-vitamin d compounds
GB1556570A (en) 1,5-disubstituted - 2 - pyrrolidones
GB1542569A (en) 2-substituted-15-heteroaryl-16,17,18,19,20-pentanor-prostaglandins
IL52424A0 (en) 2,6-methano-2h-1-benzoxocins
ZA777188B (en) Substituted 2,1,3-benzothiadiazine compounds
IL52152A (en) 3,5,5-trimethylhexonoyl ferrocene
GB1522923A (en) 1,4 - benzodiazepines
AU2468877A (en) 1,4 -dicyanobytene
PH14105A (en) 1,2,3-thiadiazol-5-yl-ureas
GB1537635A (en) 15,16-dihydroxyprostaglandins
AU3191777A (en) 1,4-oxathianes
AU3178777A (en) Substituted 4,5-dihydroxy-imidazolidine-2-thiones
MY8200244A (en) 2,3-dihydro-2-oxo-3-benzo[b]thiophenecarboxides
GB1546347A (en) 5,11-diazatetracyclo-(6.2.2.02,7 04,9)-dodecanes
ZA774088B (en) 2,5-dichloro-4-bromphenylazo-4-chloro-phenyl-sulphide
GB1554045A (en) 13,14-didehydroprostaglandins
IE841085L (en) 6-chloro-3-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine.
NZ183029A (en) Tertiary botyl (5-(1,3-dimethylureido-1,3,4-thiadiazol-2-yl-thio)-acetates
PL187575A1 (en) Sposob otrzymywania pochodnych 3,4-dwuhydro-2h-1,3-benzoksazynotionu
PL187440A1 (en) Sposob wytwarzania nowych pochodnych 3,4-dwuhydro-2h-1,3-benzoksazynotionu-2
AU2808277A (en) 4,5-dichloro-3-arylimino-1,2-dithiolewes